Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 18/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 15/20 | 0.52 |
| ▸ | CDK2 | P24941 | 1/20 | 0.47 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.47 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6315576 | 0.89 | PTGS2 (0.50) | PTGS2PTGS1ALDH1A1 | |
| SCHEMBL8549849 | 0.87 | PTGS2 (0.57) | PTGS2PTGS1CDK2ABCB11ALDH1A1 | |
| SCHEMBL6315415 | 0.87 | PTGS2 (0.50) | PTGS2PTGS1CDK2ABCB11ALDH1A1 | |
| SCHEMBL5732493 | 0.87 | PTGS2 (0.51) | PTGS2PTGS1CDK2ABCB11ALDH1A1 | |
| SCHEMBL6315005 | 0.85 | PTGS2 (0.45) | PTGS2PTGS1CDK2MEP1B | |
| SCHEMBL6314953 | 0.84 | CA9 (0.49) | PTGS2PTGS1CDK2MEP1BALDH1A1 | |
| SCHEMBL7505035 | 0.84 | PTGS2 (0.57) | PTGS2PTGS1CDK2ABCB11ALDH1A1 | |
| SCHEMBL6309705 | 0.83 | PTGS1 (0.46) | PTGS2PTGS1 | |
| SCHEMBL6315584 | 0.83 | PTGS2 (0.51) | PTGS2PTGS1CDK2ABCB11ALDH1A1 | |
| SCHEMBL6308685 | 0.83 | PTGS2 (0.60) | PTGS2PTGS1MEP1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6875785-B2 | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors | PHARMACIA CORPORATION (US) | 2005-04-05 | — | — | US | claimed |